Related references
Note: Only part of the references are listed.Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients
Marios Politis et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
Scott Ayton et al.
ANNALS OF NEUROLOGY (2013)
Quantitative and ultrastructural study of serotonin innervation of the globus pallidus in squirrel monkeys
Lara Eid et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons
Mun Kyung Sunwoo et al.
MOVEMENT DISORDERS (2013)
Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency
Roser Pons et al.
MOVEMENT DISORDERS (2013)
Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
The serotonergic system in motor and non-motor manifestations of Parkinson's disease
Philippe Huot et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias
Sven R. Suwijn et al.
EJNMMI RESEARCH (2013)
Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease
Perdita A. Cheshire et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia
K. Elisabet Ohlin et al.
BRAIN (2011)
Positive association between striatal serotonin level and abnormal involuntary movements in chronic L-DOPA-treated hemiparkinsonian rats
Suk J. Gil et al.
BRAIN RESEARCH BULLETIN (2011)
Midbrain serotonin transporters in de novo and L-DOPA-treated patients with early Parkinson's disease - a [123I]-ADAM SPECT study
J. C. Beucke et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Serotonin innervation of human basal ganglia
Marie-Josee Wallman et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter
Karl Strecker et al.
JOURNAL OF NEUROLOGY (2011)
Graft-Induced Dyskinesias in Parkinson's Disease: High Striatal Serotonin/Dopamine Transporter Ratio
Marios Politis et al.
MOVEMENT DISORDERS (2011)
Does levodopa accelerate the pathologic process in Parkinson disease brain?
L. Parkkinen et al.
NEUROLOGY (2011)
Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea
Catherine Bedard et al.
PARKINSONISM & RELATED DISORDERS (2011)
Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia
Daniella Rylander et al.
ANNALS OF NEUROLOGY (2010)
l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia
Hanna S. Lindgren et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study
Marios Politis et al.
NEUROBIOLOGY OF DISEASE (2010)
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
E. C. Tallantyre et al.
BRAIN (2009)
The Role of the Dorsal Raphe Nucleus in the Development, Expression, and Treatment of L-dopa-Induced Dyskinesia in Hemiparkinsonian Rats
Karen L. Eskow et al.
SYNAPSE (2009)
Combined 5-HTIA and 5-HTIB receptor agonists for the treatment of L-DOPA-induced dyskinesia
Ana Munoz et al.
BRAIN (2008)
The use of total protein stains as loading controls: An alternative to high-abundance single-protein controls in semi-quantitative immunoblotting
Georgina M. Aldridge et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study
P. A. Kempster et al.
BRAIN (2007)
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats
Manolo Carta et al.
BRAIN (2007)
Brain serotonin transporter binding in non-depressed patients with Parkinson's disease
M. Guttman et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications
F Calon et al.
MOVEMENT DISORDERS (2003)
Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models
F Bibbiani et al.
NEUROLOGY (2001)
Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum
A Lopez et al.
NEUROSCIENCE (2001)
Share Paper
